<DOC>
	<DOCNO>NCT00676039</DOCNO>
	<brief_summary>Generic medication equivalent brand medication exception price . Before generic medication introduce , bioequivalence within window 80 125 % original demonstrate . There report criterion always follow post-marketed period . Such investigation trigger observation patient previously stable original medication relapse switch presumable equivalent generic . Several factor could account problem . Given report problem occur antidepressant citalopram venlafaxine , pharmacokinetic property specific brand generic original examine two medication . Twelve healthy male volunteer participate crossover study . It anticipate significant difference emerge two formulation give clinical report patient deteriorate switch original generic preparation .</brief_summary>
	<brief_title>Comparison Pharmacokinetics Two Generic Antidepressants Their Respective Brand Preparations</brief_title>
	<detailed_description />
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Healthy volunteer ( absence disease : psychiatric , physical , neurological , metabolic , ... ) Psychiatric disorder Hepatic disease Renal disease Gastrointestinal disease Hematological disease Smokers Physical and/or neurological disease Positive urine drug screen Abnormal blood pressure Abnormal urine/blood analysis ( sodium , potassium , chloride , creatinine , urea , ALT , AST , total protein , glucose , TSH )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Therapeutic Equivalency</keyword>
	<keyword>Human Experimentation</keyword>
	<keyword>Bioequivalence</keyword>
	<keyword>Brand name</keyword>
	<keyword>Generic</keyword>
	<keyword>Antidepressant</keyword>
	<keyword>Healthy volunteer</keyword>
</DOC>